Sarissa Capital Management as of March 31, 2014
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 15 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ariad Pharmaceuticals | 33.3 | $97M | 12M | 8.06 | |
| Quest Diagnostics Incorporated (DGX) | 15.5 | $45M | 775k | 57.92 | |
| Bio-Reference Laboratories | 12.2 | $36M | 1.3M | 27.68 | |
| Idenix Pharmaceuticals | 10.5 | $31M | 5.1M | 6.03 | |
| Merck & Co (MRK) | 7.8 | $23M | 400k | 56.77 | |
| Mallinckrodt Pub | 6.0 | $17M | 275k | 63.41 | |
| Vivus | 5.3 | $15M | 2.6M | 5.94 | |
| Repros Therapeutics | 3.4 | $9.9M | 561k | 17.74 | |
| AVEO Pharmaceuticals | 1.3 | $3.8M | 2.6M | 1.49 | |
| Laboratory Corp. of America Holdings (LH) | 1.3 | $3.7M | 38k | 98.22 | |
| Intra Cellular Therapies (ITCI) | 0.8 | $2.3M | 127k | 18.18 | |
| Onconova Therapeutics | 0.8 | $2.2M | 350k | 6.34 | |
| Enanta Pharmaceuticals (ENTA) | 0.7 | $2.0M | 50k | 40.00 | |
| Kindred Biosciences | 0.7 | $1.9M | 102k | 18.53 | |
| Targacept | 0.5 | $1.6M | 330k | 4.75 |
